Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures
Public ClinicalTrials.gov record NCT00955357. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter, Multinational Study of Lacosamide as First Add-On Anti-epileptic Drug (AED) Treatment in Subjects With Partial-Onset Seizures
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the efficacy and safety of oral Lacosamide as first add on treatment in subjects with uncontrolled partial-onset seizures after prior treatment with a monotherapy Antiepileptic Drug (AED) regimen compared to subjects who have received treatment with at least 2 AEDs.
Study identification
- NCT ID
- NCT00955357
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 461 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 17 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2009 (Type not available)
- Primary completion
- Apr 2013 (Actual)
- Completion
- Aug 2013 (Actual)
- Last update posted
- Jul 17, 2018
2009 – 2013
United States locations
- U.S. sites
- 40
- U.S. states
- 20
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 103 | Irvine | California | — | — |
| 123 | Rancho Mirage | California | — | — |
| 156 | Clearwater | Florida | — | — |
| 157 | Destin | Florida | — | — |
| 140 | Hollywood | Florida | — | — |
| 161 | Ocala | Florida | — | — |
| 108 | Atlanta | Georgia | — | — |
| 112 | Atlanta | Georgia | — | — |
| 124 | Augusta | Georgia | — | — |
| 115 | Macon | Georgia | — | — |
| 118 | Rome | Georgia | — | — |
| 128 | Flossmoor | Illinois | — | — |
| 130 | Des Moines | Iowa | — | — |
| 102 | Bowling Green | Kentucky | — | — |
| 117 | Paducah | Kentucky | — | — |
| 107 | Houma | Louisiana | — | — |
| 145 | Ruston | Louisiana | — | — |
| 101 | Annapolis | Maryland | — | — |
| 162 | Waldorf | Maryland | — | — |
| 153 | Boston | Massachusetts | — | — |
| 136 | Pittsfield | Massachusetts | — | — |
| 144 | Springfield | Massachusetts | — | — |
| 151 | Kansas City | Missouri | — | — |
| 114 | Paterson | New Jersey | — | — |
| 109 | Brooklyn | New York | — | — |
| 133 | Brooklyn | New York | — | — |
| 127 | West Seneca | New York | — | — |
| 158 | Charlotte | North Carolina | — | — |
| 139 | Bismarck | North Dakota | — | — |
| 134 | Akron | Ohio | — | — |
| 150 | Canton | Ohio | — | — |
| 141 | Tulsa | Oklahoma | — | — |
| 121 | Indiana | Pennsylvania | — | — |
| 120 | Columbia | South Carolina | — | — |
| 149 | Orangeburg | South Carolina | — | — |
| 152 | Spartanburg | South Carolina | — | — |
| 148 | Austin | Texas | — | — |
| 154 | Dallas | Texas | — | — |
| 146 | Tomball | Texas | — | — |
| 119 | Fredericksburg | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 69 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00955357, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 17, 2018 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00955357 live on ClinicalTrials.gov.